The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Open accessAbstract
Inheritance of a defect in a neuronal mechanism that regulates response to auditory stimuli was studied in nine families with multiple cases of schizophrenia. The defect, a decrease in the normal inhibition of the P50 auditory-evoked response to the second of paired stimuli, is associated with attentional disturbances in schizophrenia. Decreased P50 inhibition occurs not only in most schizophrenics, but also in many of their nonschizophrenic relatives, in a distribution consistent with inherited vulnerability for the illness. Neurobiological investigations in both humans and animal models indicated that decreased function of the α7-nicotinic cholinergic receptor could underlie the physiological defect. In the present study, a genome-wide linkage analysis, assuming autosomal dominant transmission, showed that the defect is linked [maximum logarithm of the odds (lod) score = 5.3 with zero recombination] to a dinucleotide polymorphism at chromosome 15q13-14, the site of the α7-nicotinic receptor. Despite many schizophrenics’ extremely heavy nicotine use, nicotinic receptors were not previously thought to be involved in schizophrenia. The linkage data thus provide unique new evidence that the α7-nicotinic receptor gene may be responsible for the inheritance of a pathophysiological aspect of the illness.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In families affected with multiple cases of schizophrenia, the deficit in P50 gating segregates as an autosomal dominant and is linked to the CHRNA7 gene complex, which forms the α7-nicotinic acetylcholine receptor (26).”
From Sensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia (2015) · cites this paper as [26]
Citations
Cites
Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,946
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,686
Parametric and nonparametric linkage analysis: a unified multipoint approach.
Kruglyak, L., Daly, M. J., Daly, M. J., & Lander, E. S. (1996) · PubMed Central · Cited by 2,883
Self-citationStrategies for multilocus linkage analysis in humans.
Lathrop, M. G., Lalouel, J.-M., Julier, C., & Ott, J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.11.3443 · Cited by 2,560
Progress in experimental personality research
Maher, W. B., & Maher, B. A. (1964) · Academic Press eBooks · Cited by 2,347
Schizotaxia, schizotypy, schizophrenia.
Meehl, P. E. (1962) · American Psychologist · doi:10.1037/h0041029 · Cited by 2,036
Analysis of Human Genetic Linkage.
Edwards, A. W. F., & Ott, J. (1992) · Biometrics · doi:10.2307/2532370 · Cited by 1,691
Gating and Habituation of the Startle Reflex in Schizophrenic Patients
Braff, D. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820030038005 · Cited by 1,027
Couturier, S., Bertrand, D., Matter, J., Hernandez, M., Bertrand, S., Millar, N. S., Valera, S., BARKAS, T., & Ballivet, M. (1990) · Neuron · doi:10.1016/0896-6273(90)90344-f · Cited by 941
Adler, L. E., Pachtman, E., Franks, R. D., Pecevich, M., Waldo, M. C., & Freedman, R. (1982) · PubMed · Cited by 896
Self-citation
Flagged first, then by citations
1 of the 63 references couldn’t be matched to a known paper.
Research works printed but not linked: 8
- J-M Lalouel Am J Hum Genet 37, 700–718 (1985).
- L E Adler, E Pachtman, R Franks, M Pecevich, M C Waldo, R Freedman Biol Psychiatry 17, 639–654 (1982).
- W R Goff, P D Williamson, C VanGilder, R Allison, T C Fisher Prog Clin Neurophysiol 7, 126–145 (1980).
- L Kruglyak, M J Daly, M P Reeve-Daly, E S Lander Am J Hum Genet 58, 1347–1363 (1996).
- L Kruglyak, E S Lander Am J Hum Genet 57, 519–527 (1995).
- M Melissari, G Giordano, P Crafa, M Martella, R Ricci Pathologica 87, 78–81 (1995).
- L K Casaubon, M Melanson, I Lopes-Cendes, C Marineau, E Andersmann, F Andersmann, J Weissenbach, C Prevost, J P Bouchard, J Matheiu, G A Rouleau Am J Hum Genet 58, 28–34 (1996).
- 10.1002/(SICI)1096-8628(19960409)67:2<154::AID-AJMG5>3.0.CO;2-S · DOI
Cited by
Sorted by citations
Items 101–200 of 1,000
Doyle, A. E., Faraone, S. V., Seidman, L. J., Willcutt, E. G., Nigg, J. T., Waldman, I. D., Pennington, B. F., Peart, J., & Biederman, J. (2005) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2005.01476.x · Cited by 222
Schizophrenia and the α7 Nicotinic Acetylcholine Receptor
Martin, L. F., & Freedman, R. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78008-4 · Cited by 213
Self-citationPreattentional and attentional cognitive deficits as targets for treating schizophrenia
BRAFF, D. L., & Light, G. A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1848-0 · Cited by 213
Centrotemporal spikes in families with rolandic epilepsy
Neubauer, B. A., Fiedler, B., Himmelein, B., Kämpfer, F., Läßker, U., Schwabe, G., Spanier, I., Tams, D., Bretscher, C., Moldenhauer, K., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1608 · Cited by 215
Freedman, R., Adams, C. E., & Leonard, S. S. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00109-5 · Cited by 212
Self-citationThe Evolution of Drug Development in Schizophrenia: Past Issues and Future Opportunities
Carpenter, W. T., & Koenig, J. I. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301639 · Cited by 218
The α7 nicotinic acetylcholine receptor in neuronal plasticity
Broide, R. S., & Leslie, F. M. (1999) · Molecular Neurobiology · doi:10.1007/bf02741361 · Cited by 216
Normal P50 Suppression in Schizophrenia Patients Treated With Atypical Antipsychotic Medications
Light, G. A., Geyer, M. A., Clementz, B. A., Cadenhead, K. S., & BRAFF, D. L. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.767 · Cited by 206
Nicotinic Modulation of Glutamate and GABA Synaptic Transmission in Hippocampal Neurons
RADCLIFFE, K. A., FISHER, J. L., GRAY, R., & DANI, J. A. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb11332.x · Cited by 205
Chan, R. C. K., & Gottesman, I. I. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.01.005 · Cited by 204
Neurophysiological Endophenotypes Across Bipolar and Schizophrenia Psychosis
Thaker, G. K. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn049 · Cited by 203
Benowitz, N. L. (1999) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(05)70120-2 · Cited by 211
Cannabis and cognitive dysfunction: Parallels with endophenotypes of schizophrenia?
Solowij, N., & Michie, P. T. (2007) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0705 · Cited by 202
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders
Sacco, K. A., Bannon, K. L., & George, T. P. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104047273 · Cited by 203
Glucocorticoid hormones and early brain development in schizophrenia
Ph.D., J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00396-7 · Cited by 199
α-Conotoxin MII Blocks Nicotine-Stimulated Dopamine Release in Rat Striatal Synaptosomes
Kulak, J. M., Nguyen, T. A., Olivera, B. M., & McIntosh, J. M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05263.1997 · Cited by 198
Thaker, G. K., & Carpenter, W. T. (2001) · Nature Medicine · doi:10.1038/89040 · Cited by 203
Cadenhead, K. S., Light, G. A., Geyer, M. A., & Braff, D. L. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.55 · Cited by 198
Toward Reformulating the Diagnosis of Schizophrenia
Tsuang, M. T., Stone, W. S., & Faraone, S. V. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.7.1041 · Cited by 198
Sudweeks, S. N., & Yakel, J. L. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00515.x · Cited by 197
Lewis, D. A. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00393-1 · Cited by 201
Varied Effects of Atypical Neuroleptics on P50 Auditory Gating in Schizophrenia Patients
Adler, L. E., D, A. O. M., Cawthra, E. M., McRae, K. A., Harris, J. G., Nagamoto, H. T., Waldo, M. C., Hall, M., Bowles, A., Woodward, L., et al. (2004) · American Journal of Psychiatry · doi:10.1176/ajp.161.10.1822 · Cited by 196
Self-citationWishka, D. G., Walker, D. P., Yates, K. M., Reitz, S. C., Jia, S., Myers, J. K., Olson, K. L., Jacobsen, E. J., Wolfe, M. L., Groppi, V. E., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0602413 · Cited by 194
Clementz, B. A., & Blumenfeld, L. D. (2001) · Experimental Brain Research · doi:10.1007/s002210100744 · Cited by 193
Ho, B., Wassink, T. H., OʼLeary, D. S., Sheffield, V. C., & Andreasen, N. C. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001616 · Cited by 194
Molecular genetic studies of ADHD: 1991 to 2004
Bobb, A. J., Castellanos, F. X., Addington, A. M., & Rapoport, J. L. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30086 · Cited by 195
The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function
Sinkus, M. L., Graw, S. L., Freedman, R., Ross, R. G., Lester, H. A., & Leonard, S. S. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.02.006 · Cited by 191
Self-citationWilliams, J. T., Begleiter, H., Porjesz, B., Edenberg, H. J., Foroud, T., Reich, T., Goate, A., Eerdewegh, P. V., Almasy, L. A., & Blangero, J. (1999) · The American Journal of Human Genetics · doi:10.1086/302571 · Cited by 185
Genetics of Schizophrenia and the New Millennium: Progress and Pitfalls
Baron, M. (2001) · The American Journal of Human Genetics · doi:10.1086/318212 · Cited by 184
Friedman, J. I. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1794-x · Cited by 183
Regulation of synaptic transmission and plasticity by neuronal nicotinic acetylcholine receptors
McKay, B. E., Placzek, A. N., & Dani, J. A. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.001 · Cited by 181
Nicotinic receptors in human brain: topography and pathology
Court, J. A., Martin-Ruiz, C., Graham, A., & Perry, E. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00110-1 · Cited by 180
Relative Risk of Attention Deficits in Siblings of Patients With Schizophrenia
Egan, M. F., Goldberg, T. E., Gscheidle, T., Weirich, M. L., Bigelow, L. B., & Weinberger, D. R. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.8.1309 · Cited by 180
Diaz, F. J., James, D., Botts, S., Maw, L., Susce, M. T., & De Leon, J. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00664.x · Cited by 179
Cubells, J. F., Kranzler, H. R., McCance‐Katz, E. F., Anderson, G. M., Malison, R. T., Price, L. H., & Gelernter, J. E. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000657 · Cited by 179
Smoking and schizophrenia: abnormal nicotinic receptor expression
Leonard, S., Breese, C., Adams, C., Benhammou, K., Gault, J., Stevens, K., Lee, M., Adler, L., Olincy, A., Ross, R., et al. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00035-2 · Cited by 177
Self-citationLieberman, J. A., Dunbar, G. C., Segreti, A. C., Girgis, R. R., Seoane, F., Beaver, J. S., Duan, N., & Hosford, D. A. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.259 · Cited by 176
Dépatie, L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00372-x · Cited by 175
Desensitized nicotinic receptors in brain
Wang, H., & Sun, X. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.09.003 · Cited by 175
Neuronal nicotinic receptors: from structure to function
Bertrand, D. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200110050213 · Cited by 175
Olale, F., Gerzanich, V., Kuryatov, A., Wang, F., & Lindstrom, J. M. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37064-8 · Cited by 174
Endophenotypes in psychiatric genetics
Walters, J., & Owen, M. J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002068 · Cited by 174
Zammit, S., Spurlock, G., Williams, H. J., Norton, N., Williams, N. M., O’Donovan, M. C., & Owen, M. J. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.036129 · Cited by 171
Weiser, M., Reichenberg, A., Grotto, I., Yasvitzky, R., Rabinowitz, J., Lubin, G., Nahon, D., Knobler, H. Y., & Davidson, M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1219 · Cited by 173
Science and Recovery in Schizophrenia
Lieberman, J. A., Drake, R. E., Sederer, L. I., Belger, A., Keefe, R. S. E., Perkins, D. O., & Stroup, T. S. (2008) · Psychiatric Services · doi:10.1176/ps.2008.59.5.487 · Cited by 174
Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders
de León, J., Díaz, F. J., Rogers, T. J., Browne, D., & Dinsmore, L. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00217-1 · Cited by 168
Friedman, J. I., Adler, D. N., Howanitz, E. M., Harvey, P. D., Brenner, G. H., Temporini, H. D., WHITE, L. E., & Parrella, M. J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01342-7 · Cited by 168
Leiser, S., Bowlby, M., Comery, T., & Dunlop, J. (2009) · Pharmacology and Therapeutics · doi:10.1016/j.pharmthera.2009.03.009 · Cited by 167
Perinatal Choline Effects on Neonatal Pathophysiology Related to Later Schizophrenia Risk
Ross, R. G., Hunter, S. K., McCarthy, L., Beuler, J., Hutchison, A. K., Wagner, B. D., Leonard, S., Stevens, K. E., & Freedman, R. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12070940 · Cited by 165
“5 for the P50 ratio have previously been associated with variants in the CHRNA7 gene complex, including transmission of alleles that segregate with schizophrenia (33).”
BackgroundSelf-citationWilde, O. B.-D., Bour, L. J., Dingemans, P. M. A. J., Koelman, J. H. T. M., & LINSZEN, D. H. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.04.028 · Cited by 163
Paternal Factors and Schizophrenia Risk: De Novo Mutations and Imprinting
Malaspina, D. (2001) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006882 · Cited by 162
Turecki, G., Grof, P., Grof, E., D’Souza, V., Lebuis, L., Marineau, C., Cavazzoni, P. A., Duffy, A. C., Bétard, C., Zvolský, P., et al. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000888 · Cited by 162
Nicotine, Brain Nicotinic Receptors, and Neuropsychiatric Disorders
Mihailescu, S., & Drucker-Colı́n, R. (2000) · Archives of Medical Research · doi:10.1016/s0188-4409(99)00087-9 · Cited by 162
The use of neurophysiological endophenotypes to understand the genetic basis of schizophrenia
BRAFF, D. L., & Light, G. A. (2005) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2005.7.2/dlbraff · Cited by 161
Tobacco Use Before, At, and After First-Episode Psychosis: A Systematic Meta-Analysis
Myles, N., Newall, H. D., Curtis, J., Nielssen, O., Shiers, D., & Large, M. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11r07222 · Cited by 158
Maziade, M., Roy, M.-A., Chagnon, Y. C., Cliche, D., Fournier, J.-P., Montgrain, N., Dion, C., Lavallée, J.-C., Garneau, Y., Gingras, N., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001594 · Cited by 157
Localization of nAChR subunit mRNAs in the brain of Macaca mulatta
Han, Z., Le Novère, N., Zoli, M., Hill, J. A., Champtiaux, N., & Changeux, J. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00262.x · Cited by 156
Egan, M. F., & Weinberger, D. R. (1997) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(97)80092-x · Cited by 158
α7-Nicotinic Acetylcholine Receptor Agonists for Cognitive Enhancement in Schizophrenia
Freedman, R. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-092112-142937 · Cited by 161
Self-citationStraub, R. E., Sullivan, P. F., Ma, Y., Myakishev, M. V., Harris-Kerr, C., Wormley, B., Kadambi, B., Sadek, H., Silverman, M. A., Webb, B. T., et al. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000518 · Cited by 154
The genetics of sensory gating deficits in schizophrenia
Freedman, R., Olincy, A., Ross, R. G., Waldo, M. C., Stevens, K. E., Adler, L. E., & Leonard, S. (2003) · Current Psychiatry Reports · doi:10.1007/s11920-003-0032-2 · Cited by 153
Self-citationO’Tuathaigh, C. M. P., Babovic, D., O’Meara, G. F., Clifford, J. J., Croke, D. T., & Waddington, J. L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.04.002 · Cited by 154
Prevalence of smoking in psychiatric patients
Poirier, M.-F., Canceil, O., Baylé, F., Millet, B., Bourdel, M.-C., Moatti, C., Olié, J.-P., & Attar-Lévy, D. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00304-9 · Cited by 150
Erwin, R. J., Turetsky, B. I., Moberg, P. J., Gur, R. C., & Gur, R. E. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00075-9 · Cited by 152
The genetics of attention deficit hyperactivity disorder
Waldman, I. D., & Gizer, I. R. (2006) · Clinical Psychology Review · doi:10.1016/j.cpr.2006.01.007 · Cited by 154
Batel, P. (2000) · European Psychiatry · doi:10.1016/s0924-9338(00)00203-0 · Cited by 145
Alternative phenotypes for the complex genetics of schizophrenia
Freedman, R., Adler, L. E., & Leonard, S. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00321-7 · Cited by 144
Self-citationTregellas, J. R., Davalos, D. B., Rojas, D. C., Waldo, M. C., Gibson, L., Wylie, K., Du, Y. P., & Freedman, R. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.12.033 · Cited by 143
Self-citationKisley, M. A., Noecker, T. L., & Guinther, P. M. (2004) · Psychophysiology · doi:10.1111/j.1469-8986.2004.00191.x · Cited by 143
Confirmed rare copy number variants implicate novel genes in schizophrenia
Tam, G. W. C., van de Lagemaat, L. N., Redon, R., Strathdee, K. E., Croning, M. D. R., Malloy, M. P., Muir, W. J., Pickard, B. S., Deary, I. J., Blackwood, D. H. R., et al. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380445 · Cited by 139
A gating mechanism proposed from a simulation of a human α7 nicotinic acetylcholine receptor
Law, R. J., Henchman, R. H., & McCammon, J. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407739102 · Cited by 137
PET Studies of the Influences of Nicotine on Neural Systems in Cigarette Smokers
Rose, J. E., Behm, F. M., Westman, E. C., Mathew, R. J., London, E. D., Hawk, T. C., Turkington, T. G., & Coleman, R. E. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.323 · Cited by 136
Improvement in Smooth Pursuit Eye Movements after Cigarette Smoking in Schizophrenic Patients
D, A. O. M. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00095-x · Cited by 136
Elementary phenotypes in the neurobiological and genetic study of schizophrenia
Adler, L. E., Freedman, R., Ross, R. G., D, A. O. M., & Waldo, M. C. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00085-2 · Cited by 136
Self-citationNeylan, T. C., Fletcher, D. J., Lenoci, M., McCallin, K., Weiss, D. S., Schoenfeld, F. B., Marmar, C. R., & Fein, G. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00047-5 · Cited by 134
Seizures accelerate anoxia-induced neuronal death in the neonatal rat hippocampus
Dzhala, V. I., Ben‐Ari, Y., & Khazipov, R. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200010)48:4 · Cited by 82
Hallucinations in schizophrenia, sensory impairment, and brain disease: A unifying model
Behrendt, R., & Young, C. (2004) · Behavioral and Brain Sciences · doi:10.1017/s0140525x04000184 · Cited by 137
Straub, R. E., MacLean, C. J., Ma, Y., Webb, B. T., Myakishev, M. V., Harris-Kerr, C., Wormley, B., Sadek, H., Kadambi, B., O’Neill, F. A., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001051 · Cited by 133
Fowler, C. D., Arends, M. A., & Kenny, P. J. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c360e · Cited by 131
Treating schizophrenia symptoms with an α7 nicotinic agonist, from mice to men
D, A. O. M., & Stevens, K. E. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.015 · Cited by 131
Callicott, J. H., Egan, M. F., Bertolino, A., Mattay, V. S., Langheim, F. J. P., Frank, J. A., & Weinberger, D. R. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00264-9 · Cited by 131
Shepard, P. D., Joy, B., Prendeville, L. C., & Schwarcz, R. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300188 · Cited by 131
Genetics of Chromosome 15q13-q14 in Schizophrenia
Leonard, S. S., & Freedman, R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.054 · Cited by 130
Self-citationDissection of behavior and psychiatric disorders using the mouse as a model
Tarantino, L. M. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.6.953 · Cited by 130
Feuerbach, D., Lingenhoehl, K., Olpe, H.-R., Vassout, A., Gentsch, C., Chaperon, F., Nozulak, J., Enz, A., Bilbe, G., McAllister, K. H., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.025 · Cited by 128
Treatment of Tobacco Dependence in Mental Health and Addictive Disorders
Hitsman, B. L., Moss, T. G., Montoya, I. D., & George, T. P. (2009) · The Canadian Journal of Psychiatry · doi:10.1177/070674370905400604 · Cited by 130
Alkondon, M., Pereira, E. F. R., Barbosa, C. T. F., & Albuquerque, E. X. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37139-3 · Cited by 127
Kaufmann, C. A., Suarez, B. K., Malaspina, D., Pepple, J. R., Švrakić, D. M., Markel, P. D., Meyer, J. M., Zambuto, C. T., Schmitt, K., Matise, T. C., et al. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980710)81:4 · Cited by 266
The apolipoprotein E gene, attention, and brain function.
Parasuraman, R., Greenwood, P. M., & Sunderland, T. (2002) · Neuropsychology · doi:10.1037//0894-4105.16.2.254 · Cited by 134
Neurocognitive Deficits in Schizophrenia
Goldberg, T. E., David, A. S., & Gold, J. M. (2003) · Wiley eBooks · doi:10.1002/9780470987353.ch10 · Cited by 127
Tropisetron improves deficits in auditory P50 suppression in schizophrenia
Koike, K., Hashimoto, K., Takai, N., Shimizu, E., Komatsu, N., Watanabe, H., Nakazato, M., Okamura, N., Stevens, K. E., Freedman, R., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2004.12.016 · Cited by 126
Self-citationGenetics of Smoking and Schizophrenia
Leonard, S. S., Mexal, S., & Freedman, R. (2007) · Journal of Dual Diagnosis · doi:10.1300/j374v03n03_05 · Cited by 124
Self-citationGenes, Experience, and Chance in Schizophrenia--Positioning for the 21st Century
Moldin, S. O., & Gottesman, I. I. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.4.547 · Cited by 124
P50 suppression in recent-onset schizophrenia: Clinical correlates and risperidone effects.
Yee, C. M., Nuechterlein, K. H., Morris, S. E., & White, P. M. (1998) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.107.4.691 · Cited by 124
Ross, R. G., Hunter, S. K., Hoffman, M. C., McCarthy, L., Chambers, B. M., Law, A. J., Leonard, S., Zerbe, G. O., & Freedman, R. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15091188 · Cited by 123
“parameters—Child Behavior Checklist subscales, dichotomization of P50 S2/S1 ratios, and CHRNA7 genotype—were specified in previous studies (5, 22, 27, 28, 34).”
MethodSelf-citationEndophenotypes of obsessive-compulsive disorder: rationale, evidence and future potential
Chamberlain, S. R., & Menzies, L. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.36 · Cited by 123
Young, J. W., & Geyer, M. A. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.031 · Cited by 128
Maelicke, A., Schrattenholz, A. S., Samochocki, M., Radina, M., & Albuquerque, E. X. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00214-x · Cited by 125
The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia
Moises, H. W., Zoëga, T., & Gottesman, I. I. (2002) · BMC Psychiatry · doi:10.1186/1471-244x-2-8 · Cited by 123
Araud, T., Graw, S. L., Berger, R., Lee, M., Neveu, E., Bertrand, D., & Leonard, S. S. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.018 · Cited by 128
Self-citation
Metadata
- Authors
- Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., Rosenthal, J., Waldo, M. C., Reimherr, F., Wender, P., Yaw, J., Young, D. A., Breese, C. R., Adams, C., Patterson, D., Adler, L. E., Kruglyak, L., Leonard, S., & Byerley, W.
- Affiliations
- Baylor College of Medicine (US)
- Departments of Psychiatry, Pharmacology, Biochemistry, and Preventive Medicine and Biophysics, University of Colorado School of Medicine, Denver Veterans Affairs Medical Center, and Eleanor Roosevelt Institute for Cancer Research, Denver, CO 80262; Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT 84132; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030-3498; National Center for Human Genome Research/National Institutes of...
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1997-01-21
- Volume
- 94
- Issue
- 2
- Pages
- 587-592
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC19557
- OpenAlex
- W2144671685
- Cited by
- 1,141
- References
- 63
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 6 · 2023: 7 · 2022: 10 · 2021: 11 · 2020: 16 · 2019: 15 · 2018: 6 · 2017: 14 · 2016: 19 · 2015: 46 · 2014: 25 · 2013: 28 · 2012: 39
- FWCI
- 62.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- National Institutes of Health (5k02mh001089-03, 1f32mh010168-01, DA09457)
- National Institute on Aging (T32AG000029)
- National Institute of Mental Health (MH-44212, P50MH044212, MH01089, MH-10168-F32)
- National Institute on Drug Abuse (R01DA009457)
- National Center for Research Resources (P41RR003655, M01RR000064)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- schizophrenia, alpha7 nicotinic acetylcholine receptor, genetic linkage, autosomal dominant inheritance, attention deficits, family-based genetic study, nicotine use
- MeSH terms
- Auditory Perception, Chromosomes, Human, Pair 15, Evoked Potentials, Female, Genes, Genetic Markers, Humans, Genetic Linkage, Male, Pedigree, Receptors, Nicotinic, Schizophrenia, Chromosomes, Artificial, Yeast
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review